Benitec Biopharma (BNTC) News Today → Don’t buy a single NVIDIA share before you see this... (From Behind the Markets) (Ad) Free BNTC Stock Alerts $7.65 +0.10 (+1.32%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29 at 11:09 PM | marketbeat.comBenitec Biopharma Inc. (NASDAQ:BNTC) Sees Large Decline in Short InterestBenitec Biopharma Inc. (NASDAQ:BNTC - Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 56,100 shares, a decline of 43.0% from the April 30th total of 98,500 shares. Based on an average trading volume of 87,400 shares, the days-to-cover ratio is currently 0.6 days. Approximately 2.5% of the company's stock are short sold.May 20, 2024 | markets.businessinsider.comBuy Rating for Benitec Biopharma on Promising Early-Stage Clinical Data and Solid FinancialsMay 18, 2024 | marketbeat.comBenitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50 Day Moving Average of $6.50Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above Fifty Day Moving Average of $6.50May 13, 2024 | finance.yahoo.comBenitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational UpdateMay 13, 2024 | investorplace.comBNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024May 1, 2024 | finance.yahoo.comBenitec Biopharma to Participate in the Citizens JMP Life Science ConferenceApril 18, 2024 | msn.comWhy Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?April 18, 2024 | marketbeat.comTrading was temporarily halted for "BNTC" at 09:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 18, 2024 | marketbeat.comTrading was temporarily halted for "BNTC" at 09:04 AM with a stated reason of "LULD pause."April 18, 2024 | finanznachrichten.deBenitec Biopharma Inc.: Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a StudyApril 18, 2024 | msn.comBenitec Biopharma jumps 33% on $40M private financingApril 18, 2024 | markets.businessinsider.comWhy Benitec Biopharma Is Rising In Pre-market?April 18, 2024 | globenewswire.comBenitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a StudyApril 18, 2024 | globenewswire.comBenitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 MillionApril 9, 2024 | finance.yahoo.comBenitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024March 24, 2024 | insidermonkey.com11 Best ASX Stocks To Buy NowFebruary 25, 2024 | msn.comBenitec Biopharma (BNTC) Price Target Increased by 66.67% to 10.20February 13, 2024 | finance.yahoo.comBenitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational UpdateNovember 30, 2023 | finance.yahoo.comHere's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Compensation Is The Least Of Shareholders ConcernsNovember 30, 2023 | finance.yahoo.comBenitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyNovember 19, 2023 | morningstar.comBenitec Biopharma Inc BNTCNovember 17, 2023 | finance.yahoo.comBenitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare ConferenceNovember 15, 2023 | finanznachrichten.deBenitec Biopharma Inc.: Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateNovember 14, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Benitec Biopharma (BNTC), Rezolute (RZLT)November 13, 2023 | finance.yahoo.comBenitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational UpdateSeptember 27, 2023 | msn.comJMP Securities Maintains Benitec Biopharma (BNTC) Market Outperform RecommendationSeptember 26, 2023 | markets.businessinsider.comJMP Securities Sticks to Its Buy Rating for Benitec Biopharma (BNTC)September 21, 2023 | finance.yahoo.comBenitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational UpdateAugust 21, 2023 | finance.yahoo.comCitadel Advisors LLC Acquires New Stake in Benitec Biopharma IncAugust 11, 2023 | finance.yahoo.comBenitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public OfferingAugust 9, 2023 | marketbeat.comTrading was temporarily halted for "BNTC" at 10:08 AM with a stated reason of "LULD pause." Trading set to resume at 10:08 AM. August 9, 2023 | marketbeat.comTrading was temporarily halted for "BNTC" at 10:08 AM with a stated reason of "LULD pause."August 9, 2023 | msn.comBenitec Biopharma prices $30M equity offeringAugust 9, 2023 | finance.yahoo.comBenitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public OfferingAugust 2, 2023 | msn.comBenitec Biopharma (BNTC) Price Target Increased by 1600.00% to 69.36July 28, 2023 | barrons.comBenitec Biopharma Inc.July 27, 2023 | finance.yahoo.comBenitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023July 26, 2023 | marketbeat.comTrading was temporarily halted for "BNTC" at 10:07 AM with a stated reason of "LULD pause." Trading set to resume at 10:07 AM. June 26, 2023 | marketwatch.comBenitec Biopharma Receives FDA Clearance of IND for BB-301June 26, 2023 | marketwatch.comBenitec Biopharma Shares Double on FDA ClearanceJune 26, 2023 | msn.comWhat In The World Is Going On With Benetic Biopharma (BNTC) StockJune 26, 2023 | finance.yahoo.comBenitec Biopharma Receives FDA Clearance of the IND for BB-301 for the Treatment of Oculopharyngeal Muscular DystrophyMay 18, 2023 | msn.comJMP Securities Reiterates Benitec Biopharma (BNTC) Market Outperform RecommendationMay 18, 2023 | markets.businessinsider.comJMP Securities Remains a Buy on Benitec Biopharma (BNTC)May 16, 2023 | marketwatch.com8-K: Benitec Biopharma Inc.May 15, 2023 | finanznachrichten.deBenitec Biopharma Inc.: Benitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateMay 15, 2023 | finance.yahoo.comBenitec Biopharma Releases Third Quarter 2023 Financial Results and Provides Operational UpdateMay 8, 2023 | finance.yahoo.comBenitec Biopharma to Present at the JMP Securities Life Sciences ConferenceApril 14, 2023 | nbcnews.comMore than 200 drugmakers led by Pfizer blast Texas judge's abortion pill decisionMarch 1, 2023 | seekingalpha.comBNTC Benitec Biopharma Inc. Get Benitec Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care. I have uncovered a bombshell that changes everything… and threatens everything. BNTC Media Mentions By Week BNTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTC News Sentiment▼1.580.79▲Average Medical News Sentiment BNTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTC Articles This Week▼30▲BNTC Articles Average Week Get Benitec Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SKYE News NKTX News NBTX News URGN News QTTB News AVIR News VTYX News KMDA News ADCT News VNDA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTC) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
